| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |